Revance Therapeutics shares owned by NinePointTwo Capital
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by NinePointTwo Capital
from 13F filings
Historical chart of NinePointTwo Capital investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by NinePointTwo Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by NinePointTwo Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $329k | 38k | 8.77 |
| 2023-06-30 | $213k | 8.4k | 25.23 |
| 2022-12-31 | $217k | 12k | 18.43 |